Impact of urinary incontinence on healthcare resource utilization, health‐related quality of life and productivity in patients with overactive bladder

By  

BJU INTERNATIONAL, Vol. 113, Iss. 3, 2014-03 ,pp. : 484-491

John Wiley & Sons Inc

Access to resources Recommend Favorite

A cost-utility analysis of once daily solifenacin compared to tolterodine in the treatment of overactive bladder syndrome

By Speakman Mark   Khullar Vik   Mundy Anthony   Odeyemi Isaac   Bolodeoku John  

Current Medical Research and Opinion, Vol. 24, Iss. 8, 2008-08 ,pp. : 2173-2179

Informa Healthcare

Access to resources Recommend Favorite

Solifenacin for the treatment of overactive bladder

By Robinson Dudley   Cardozo Linda  

Therapy, Vol. 8, Iss. 6, 2011-11 ,pp. : 691-701

Future Medicine

Access to resources Recommend Favorite

Impact of solifenacin on diary-recorded and patient-reported urgency in patients with severe overactive bladder (OAB) symptoms

By Serels Scott R.   Toglia Marc R.   Forero-Schwanhaeuser Sergio   He Weizhong  

Current Medical Research and Opinion, Vol. 26, Iss. 10, 2010-10 ,pp. : 2277-2285

Informa Healthcare

Access to resources Recommend Favorite

Solifenacin treatment for overactive bladder in black patients: patient-reported symptom bother and health-related quality of life outcomes

By Mallett Veronica   Burks David   Garely Alan D.   Smith Neila  

Current Medical Research and Opinion, Vol. 23, Iss. 4, 2007-04 ,pp. : 821-831

Informa Healthcare

Access to resources Recommend Favorite